150 related articles for article (PubMed ID: 13895219)
21. An investigation into the synergistic antileukemic action of amethopterin and 6-mercaptopurine in mice.
GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N; GREENHOUSE SW
J Natl Cancer Inst; 1955 Aug; 16(1):129-38. PubMed ID: 13243117
[No Abstract] [Full Text] [Related]
22. Evidence for two molecular species of dihydrofolate reductase in amethopterin resistant and sensitive cells of the mouse leukemia L4946.
Blumenthal G; Greenberg DM
Oncology; 1970; 24(3):223-9. PubMed ID: 5418574
[No Abstract] [Full Text] [Related]
23. The use of dihydrofolate reductase in studies of mixed populations of sensitive and resistant leukemic cells.
FRIEDKIN M; GOLDIN A
Cancer Res; 1962 Jun; 22():607-16. PubMed ID: 13895220
[No Abstract] [Full Text] [Related]
24. The treatment of experimental mouse hemoblastosis. 3. Chemotherapy of the LaH VUFB leukemia with some 4-amino analogues of folic acid.
Soucek J; Sochman J; Motycka K; Novotná O; Slavík K
Neoplasma; 1965; 12(4):425-33. PubMed ID: 5854414
[No Abstract] [Full Text] [Related]
25. Comparative effect of amethopterin and its 3',5'-dichloro derivative on purine biosynthesis in leukemic mice.
SCHRECKER AW; MEAD JA; LYNCH MR; GOLDIN A
Cancer Res; 1960 Jul; 20():876-86. PubMed ID: 14443540
[No Abstract] [Full Text] [Related]
26. Inhibition of dihydrofolic reductase by aminopterin and amethopterin.
OSBORN MJ; FREEMAN M; HUENNEKENS FM
Proc Soc Exp Biol Med; 1958 Feb; 97(2):429-31. PubMed ID: 13518295
[No Abstract] [Full Text] [Related]
27. Chemical changes in the tissues of leukemic mice. II. The effects of amethopterin.
CERECEDO LR; BRESNICK E
Exp Med Surg; 1961; 19():251-7. PubMed ID: 13877688
[No Abstract] [Full Text] [Related]
28. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
Matherly LH; Anderson LA; Goldman ID
Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
[TBL] [Abstract][Full Text] [Related]
29. Investigation of tumor variants recovered from mice with systemic leukemia (L1210) after extensive therapy with 3',5'-dichloroamethopterin and 3'-bromo-5'-chloroamethopterin.
HUMPHREYS SR; GOLDIN A
J Natl Cancer Inst; 1959 Oct; 23():633-53. PubMed ID: 14405382
[No Abstract] [Full Text] [Related]
30. Regulation of dihydrofolate reductase and other folate-requiring enzymes.
Bertino JR; Hillcoat BL
Adv Enzyme Regul; 1968; 6():335-49. PubMed ID: 4888607
[No Abstract] [Full Text] [Related]
31. Influence of amethopterin on tumor growth and liver glutathione levels of mice bearing lymphocytic leukemias.
LAW LW; SHACTER B
J Natl Cancer Inst; 1956 Sep; 17(3):391-8. PubMed ID: 13367809
[No Abstract] [Full Text] [Related]
32. GENETIC MODIFICATION OF THE STRUCTURE AND AMOUNT OF DIHYDROFOLATE REDUCTASE IN AMETHOPTERIN-RESISTANT DIPLOCOCCUS PNEUMONIAE.
SIROTNAK FM; DONATI GJ; HUTCHISON DJ
J Biol Chem; 1964 Dec; 239():4298-302. PubMed ID: 14247685
[No Abstract] [Full Text] [Related]
33. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
34. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
[TBL] [Abstract][Full Text] [Related]
35. DIHYDROFOLATE REDUCTASE IN GENOTYPICALLY DISTINGUISHABLE AMETHOPTERIN-RESISTANT DIPLOCOCCUS PNEUMONIAE.
SIROTNAK FM; DONATI GJ; HUTCHISON DJ
J Biol Chem; 1964 Aug; 239():2677-82. PubMed ID: 14235552
[No Abstract] [Full Text] [Related]
36. A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178Y cells.
Goldie JH; Krystal G; Hartley D; Gudauskas G; Dedhar S
Eur J Cancer (1965); 1980 Dec; 16(12):1539-46. PubMed ID: 7227429
[No Abstract] [Full Text] [Related]
37. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
[TBL] [Abstract][Full Text] [Related]
38. Effect of orally administered 3', 5'-dichloroamethopterin on formate-C14 incorporation in leukemic mice.
SCHRECKER AW; MEAD JA; LYNCH MR; VENDITTI JM; GOLDIN A
Cancer Res; 1960 Nov; 20():1457-61. PubMed ID: 13748581
[No Abstract] [Full Text] [Related]
39. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
40. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
